Literature DB >> 33395407

Alignment-free method for functional annotation of amino acid substitutions: Application on epigenetic factors involved in hematologic malignancies.

Branislava Gemović1, Vladimir Perović1, Radoslav Davidović1, Tamara Drljača1, Nevena Veljkovic1,2.   

Abstract

For the last couple of decades, there has been a significant growth in sequencing data, leading to an extraordinary increase in the number of gene variants. This places a challenge on the bioinformatics research community to develop and improve computational tools for functional annotation of new variants. Genes coding for epigenetic regulators have important roles in cancer pathogenesis and mutations in these genes show great potential as clinical biomarkers, especially in hematologic malignancies. Therefore, we developed a model that specifically focuses on these genes, with an assumption that it would outperform general models in predicting the functional effects of amino acid substitutions. EpiMut is a standalone software that implements a sequence based alignment-free method. We applied a two-step approach for generating sequence based features, relying on the biophysical and biochemical indices of amino acids and the Fourier Transform as a sequence transformation method. For each gene in the dataset, the machine learning algorithm-Naïve Bayes was used for building a model for prediction of the neutral or disease-related status of variants. EpiMut outperformed state-of-the-art tools used for comparison, PolyPhen-2, SIFT and SNAP2. Additionally, EpiMut showed the highest performance on the subset of variants positioned outside conserved functional domains of analysed proteins, which represents an important group of cancer-related variants. These results imply that EpiMut can be applied as a first choice tool in research of the impact of gene variants in epigenetic regulators, especially in the light of the biomarker role in hematologic malignancies. EpiMut is freely available at https://www.vin.bg.ac.rs/180/tools/epimut.php.

Entities:  

Year:  2021        PMID: 33395407      PMCID: PMC7781373          DOI: 10.1371/journal.pone.0244948

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  67 in total

1.  Development and validation of a computational method for assessment of missense variants in hypertrophic cardiomyopathy.

Authors:  Daniel M Jordan; Adam Kiezun; Samantha M Baxter; Vineeta Agarwala; Robert C Green; Michael F Murray; Trevor Pugh; Matthew S Lebo; Heidi L Rehm; Birgit H Funke; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2011-02-11       Impact factor: 11.025

2.  Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

Authors:  Felicitas Thol; Frederik Damm; Andrea Lüdeking; Claudia Winschel; Katharina Wagner; Michael Morgan; Haiyang Yun; Gudrun Göhring; Brigitte Schlegelberger; Dieter Hoelzer; Michael Lübbert; Lothar Kanz; Walter Fiedler; Hartmut Kirchner; Gerhard Heil; Jürgen Krauter; Arnold Ganser; Michael Heuser
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

3.  Hematologic malignancies in elderly patients.

Authors:  Moustapha Hassan; Manuchehr Abedi-Valugerdi
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

Review 4.  Variation Interpretation Predictors: Principles, Types, Performance, and Choice.

Authors:  Abhishek Niroula; Mauno Vihinen
Journal:  Hum Mutat       Date:  2016-04-15       Impact factor: 4.878

5.  Molecular damage in Fabry disease: characterization and prediction of alpha-galactosidase A pathological mutations.

Authors:  Casandra Riera; Sergio Lois; Carmen Domínguez; Israel Fernandez-Cadenas; Joan Montaner; Victor Rodríguez-Sureda; Xavier de la Cruz
Journal:  Proteins       Date:  2014-11-18

6.  Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project.

Authors:  Rafael Marcos-Gragera; Claudia Allemani; Carmen Tereanu; Roberta De Angelis; Riccardo Capocaccia; Marc Maynadie; Stefano Luminari; Stefano Ferretti; Tom Børge Johannesen; Risto Sankila; Marja-Liisa Karjalainen-Lindsberg; Arianna Simonetti; Maria Carmen Martos; Martine Raphaël; Pilar Giraldo; Milena Sant
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

7.  WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.

Authors:  Yiping Wang; Mengtao Xiao; Xiufei Chen; Leilei Chen; Yanping Xu; Lei Lv; Pu Wang; Hui Yang; Shenghong Ma; Huaipeng Lin; Bo Jiao; Ruibao Ren; Dan Ye; Kun-Liang Guan; Yue Xiong
Journal:  Mol Cell       Date:  2015-01-15       Impact factor: 17.970

8.  Requirement of clathrin heavy chain for p53-mediated transcription.

Authors:  Masato Enari; Kazuji Ohmori; Issay Kitabayashi; Yoichi Taya
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

9.  Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.

Authors:  Marc Maynadié; Roberta De Angelis; Rafael Marcos-Gragera; Otto Visser; Claudia Allemani; Carmen Tereanu; Riccardo Capocaccia; Adriano Giacomin; Jean-Michel Lutz; Carmen Martos; Risto Sankila; Tom Børge Johannesen; Arianna Simonetti; Milena Sant
Journal:  Haematologica       Date:  2012-09-14       Impact factor: 9.941

10.  Next-generation phylogenomics.

Authors:  Cheong Xin Chan; Mark A Ragan
Journal:  Biol Direct       Date:  2013-01-22       Impact factor: 4.540

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.